412
Participants
Start Date
October 15, 2019
Primary Completion Date
June 8, 2021
Study Completion Date
July 7, 2021
Placebo
4 matching placebo tablets taken twice a day (BID)
PF-06882961
Participants will be randomized to one of 5 active doses (2.5, 10, 40, 80, or 120 mg), taking 4 tablets twice daily for 16 weeks.
Far Eastern Memorial Hospital, New Taipei City
National Cheng Kung University Hospital, Tainan City
Fourth MHAT - Sofia EAD, Sofia
"MHAT Doverie AD", Sofia
Medical Center ASKLEPII OOD, Dupnitsa
CRU Hungary Kft., Miskolc
UMHAT Pulmed, Plovdiv
Belinus Orvosi es Szamitastechnikai Bt, Debrecen
Debreceni Egyetem Klinikai Kozpont, Debrecen
"MC New rehabilitation center EOOD", Stara Zagora
MHAT Dobrich AD, Dobrich
Hanyang University Guri Hospital, Guri-si
Preferred Primary Care Physicians, Inc., Pittsburgh
Ajou University Hospital, Suwon
Family Medical Associates, Levittown
Yonsei University-Wonju Severance Christian Hospital, Wŏnju
PharmQuest, Greensboro
Spartanburg Medical Research, Spartanburg
Palmetto Clinical Research, Summerville
Palmetto Primary Care Physicians (physicals only), Summerville
Ellipsis Group, Alpharetta
East Coast Institute for Research, LLC, Macon
East Coast Institute for Research, LLC, Jacksonville
East Coast Institute for Research, LLC, Jacksonville
Accel Research Sites - DeLand Clinical Research Unit, DeLand
Andres Patron D.O. P.A., Pembroke Pines
Sunshine Research Center, Inc, Opa-locka
NewPhase Clinical Trials, Corp., Miami Beach
New Horizon Research Center, Miami
Taichung Veterans General Hospital, Taichung
Velocity Clinical Research, Cincinnati
Buynak Clinical Research, Valparaiso
Lillestol Research LLC, Fargo
Cedar Crosse Research Center, Chicago
Conrad Clinical Research, Edmond
Dallas Diabetes Research Center, Dallas
Endocrine Associates, Houston
PrimeCare Medical Group, Houston
Juno Research, LLC, Houston
DM Clinical Research, Tomball
Martin Diagnostic Clinic, Tomball
Sun Research Institute, San Antonio
Northeast Clinical Research of San Antonio, Live Oak
Viable Research Management LLC, Henderson
National Research Institute, Los Angeles
Holy Trinity Medical Clinic, Harbor City
Innovative Clinical Research, Inc., Harbor City
Long Beach Clinical Trials Services, Inc., Long Beach
San Fernando Valley Health Institute, LLC, Van Nuys
Rancho Cucamonga Clinical Research, Rancho Cucamonga
Catalina Research Institute, LLC, Montclair
Empire Clinical Research, Pomona
Encompass Clinical Research, Spring Valley
University Clinical Investigators, Incorporated, Tustin
Diablo Clinical Research Incorporated, Walnut Creek
Rainier Clinical Research Center, Inc., Renton
Premier Research, Trenton
GA Research Associates Ltd., Moncton
Aggarwal and Associates Limited, Brampton
Manna Research (Toronto), Toronto
Manna Research (Quebec), Lévis
Manna Research (Mirabel), Mirabel
Diex Recherche Quebec Inc., Québec
Alpha Recherche Clinique, Québec
Diex Recherche Sherbrooke Inc., Sherbrooke
Diex Recherche Victoriaville Inc., Victoriaville
Centre de Recherche Saint-Louis, Québec
Borbanya Praxis Egeszsegugyi KFT, Nyíregyháza
Clinfan Kft., Szekszárd
Zdrowie Osteo-Medic s.c. Lidia i Artur Racewicz, Agnieszka i Jerzy Supronik, Bialystok
Medyczne Centrum Diabetologiczno-Endokrynologiczno-Metaboliczne DIAB-ENDO-MET Sp. z o. o., Krakow
Prywatny Gabinet Lekarski i Wizyty Lekarskie Jan Ruxer, Lodz
MEDICOME Sp. z o.o., Oświęcim
KO-MED CENTRA KLINICZNE Sp. z o.o. Ośrodek Badań Klinicznych w Puławach, Puławy
Centralny Szpital Kliniczny MSWiA, Warsaw
Metabol KLINIK s.r.o., Bratislava
Medispektrum, s.r.o, Bratislava
HUMAN-CARE, s.r.o., Košice
SchronerMED s.r.o., Moldava nad Bodvou
Funkystuff, s.r.o., Nové Zámky
DIAB s.r.o., Rožňava
MUDr. Jana Rociakova, s.r.o., Žilina
Samsung Medical Center, Gangnam-Gu
Lead Sponsor
Pfizer
INDUSTRY